Sharpless Calls For A Nimble, Flexible, More Efficient US FDA

 
• By Derrick Gingery
FDA acting Commissioner Ned Sharpless speaking at FDLI 2019
Acting FDA Commissioner Norman Sharpless reiterated during a speech to the Food and Drug Law Institute annual conference that he does not intend to slow the agency's progress in recent years. • Source: Ferdous Al-Faruque

More from US FDA

More from Agency Leadership